Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Could Overtime Lawsuits Spread to Pfizer? Two Claims Suggest So
BNET Pharma
Wednesday, October 27, 2010 - 5:55pm
tags:
overtime lawsuits, Pfizer, King, Alpharma
Earnings Preview: Celgene
Seeking Alpha
Wednesday, October 27, 2010 - 4:02pm
tags:
earnings, Celgene
Avanir: The Short and Long of AVP-923
TheStreet.com
Wednesday, October 27, 2010 - 4:01pm
tags:
Avanir, AVP-923
A Disappointing Diabetes-Drug Development
WSJ Online
Wednesday, October 27, 2010 - 4:00pm
tags:
diabetes, Phenomix, Forest Labs
Bristol-Myers: FDA finds problems at Puerto Rico plant; could delay approval of new drugs
Yahoo/AP
Wednesday, October 27, 2010 - 12:25pm
tags:
FDA, Bristol-Myers Squibb, drug manufacturing
P&G says net income fell 7 percent in 1Q
Yahoo/AP
Wednesday, October 27, 2010 - 12:22pm
tags:
earnings, P&G
The Single Biggest Reason we need Big Pharma Drug Discovery
Pharmareform
Wednesday, October 27, 2010 - 12:08pm
tags:
innovation, R&D, drug development, Big Pharma
AstraZeneca sues to block Watson Pharmaceuticals patent challenge on cholesterol drug Crestor
Yahoo/AP
Wednesday, October 27, 2010 - 12:07pm
tags:
Watson Pharmaceuticals, generics, Crestor, AstraZeneca
Mylan Beats on EPS, Misses on Sales
Yahoo/Zacks.com
Wednesday, October 27, 2010 - 12:06pm
tags:
Mylan, Abbott Laboratories, earnings
Look Beyond the Botched Buyout Process for Savient's Value
Seeking Alpha
Wednesday, October 27, 2010 - 11:54am
tags:
Savient
Illumina posts higher 3Q profit
Yahoo/AP
Wednesday, October 27, 2010 - 11:51am
tags:
earnings, Illumina
Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
Bloomberg
Wednesday, October 27, 2010 - 11:50am
tags:
Amgen, Prolia, UK, NHS
King Pharma Sales Rep Sues For Overtime Pay
Pharmalot
Wednesday, October 27, 2010 - 11:48am
tags:
overtime lawsuits, drug reps, King
Earnings Preview: Merck to report 3Q results
Yahoo/AP
Wednesday, October 27, 2010 - 11:43am
tags:
earnings, Merck
MacroGenics, Pfizer sign collaboration deal
Yahoo/AP
Wednesday, October 27, 2010 - 11:43am
tags:
Pfizer, Macrogenics, cancer
Myriad joins Abbott Labs' breast cancer study
Yahoo/AP
Wednesday, October 27, 2010 - 11:41am
tags:
Myriad, Abbott Laboratories, breast cancer
Provectus Gains Momentum Ahead of Upcoming Melanoma Data Presentation
Seeking Alpha
Wednesday, October 27, 2010 - 11:31am
tags:
Provectus, melanoma, oncology, dermatology
Novo Nordisk Third-Quarter Profit Beats Analyst Estimates; Forecast Raised
Bloomberg
Wednesday, October 27, 2010 - 9:17am
tags:
earnings, Novo Nordisk
Next For Arena: Layoffs, Approval, Or Both?
Forbes
Wednesday, October 27, 2010 - 9:05am
tags:
Arena Pharmaceuticals, layoffs, FDA
In Sanofi-Genzyme Deal, Both Sides Are Dancing Around Bad Information
BNET Pharma
Wednesday, October 27, 2010 - 9:02am
tags:
M&A, Sanofi, Genzyme

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.